tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PHVS Stock Latest News

Pharvaris files automatic mixed securities shelf
The FlyPharvaris files automatic mixed securities shelf
13d ago
PHVS
Pharvaris N.V.’s High-Stakes Gamble: Navigating Clinical Trials and Regulatory Hurdles for Market Success
PremiumCompany Announcements
Pharvaris N.V.’s High-Stakes Gamble: Navigating Clinical Trials and Regulatory Hurdles for Market Success
13d ago
PHVS
Pharvaris price target raised to $50 from $49 at JMP Securities
PremiumThe Fly
Pharvaris price target raised to $50 from $49 at JMP Securities
14d ago
PHVS
Pharvaris Excels in HAE Treatment Advances
PremiumCompany Announcements
Pharvaris Excels in HAE Treatment Advances
14d ago
6K
PHVS
Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PremiumPress Releases
Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
15d ago
PHVS
Pharvaris reports Q4 EPS (EUR 0.74) vs. (EUR 1.16) last year
PremiumThe FlyPharvaris reports Q4 EPS (EUR 0.74) vs. (EUR 1.16) last year
15d ago
PHVS
Pharvaris appoints David Nassif as CFO
PremiumThe Fly
Pharvaris appoints David Nassif as CFO
15d ago
PHVS
Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer
PremiumPress Releases
Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer
15d ago
PHVS
Pharvaris to Present Deucrictibant Clinical Data at the CIIC Spring 2024 Conference
PremiumPress Releases
Pharvaris to Present Deucrictibant Clinical Data at the CIIC Spring 2024 Conference
21d ago
PHVS
Pharvaris Announces Phase 3 Clinical Study Design for Recently Initiated RAPIDe-3 Study, and Presents Quality-of-Life Improvement and Caregiver Behavior Data at Two Recent HAE Congresses
PremiumPress Releases
Pharvaris Announces Phase 3 Clinical Study Design for Recently Initiated RAPIDe-3 Study, and Presents Quality-of-Life Improvement and Caregiver Behavior Data at Two Recent HAE Congresses
1M ago
PHVS
Pharvaris initiates RAPIDe-3, the Phase 3 clinical trial
PremiumThe Fly
Pharvaris initiates RAPIDe-3, the Phase 3 clinical trial
1M ago
PHVS
Pharvaris files to sell 5.55M ordinary shares for holders
PremiumThe Fly
Pharvaris files to sell 5.55M ordinary shares for holders
2M ago
PHVS
Pharvaris to Present Deucrictibant Clinical Data at Upcoming Congresses
PremiumPress ReleasesPharvaris to Present Deucrictibant Clinical Data at Upcoming Congresses
2M ago
PHVS
Pharvaris to Participate in the Leerink Global Biopharma Conference 2024
PremiumPress Releases
Pharvaris to Participate in the Leerink Global Biopharma Conference 2024
2M ago
PHVS
Pharvaris’ deucrictibant shows positive results in HAE attacks
PremiumThe Fly
Pharvaris’ deucrictibant shows positive results in HAE attacks
2M ago
PHVS
Positive Results from CHAPTER-1 Phase 2 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks to be Presented at AAAAI 2024 Annual Meeting
PremiumPress Releases
Positive Results from CHAPTER-1 Phase 2 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks to be Presented at AAAAI 2024 Annual Meeting
2M ago
PHVS
Pharvaris Announces Extraordinary Meeting of Shareholders
PremiumPress Releases
Pharvaris Announces Extraordinary Meeting of Shareholders
2M ago
PHVS
Pharvaris to Present at the WSAAI Annual Meeting 2024
PremiumPress Releases
Pharvaris to Present at the WSAAI Annual Meeting 2024
3M ago
PHVS
Pharvaris price target raised to $13 from $11 at BofA
PremiumThe Fly
Pharvaris price target raised to $13 from $11 at BofA
3M ago
BCRX
IONS
Pharvaris price target raised to $49 from $40 at JMP Securities
PremiumThe FlyPharvaris price target raised to $49 from $40 at JMP Securities
3M ago
PHVS
Morgan Stanley expects Pharvaris to be up 10-15% after FDA lifts clinical hold
PremiumThe Fly
Morgan Stanley expects Pharvaris to be up 10-15% after FDA lifts clinical hold
3M ago
PHVS
Pharvaris Announces FDA Lifting of the Clinical Hold of Deucrictibant for the Prophylactic Treatment of HAE Attacks
PremiumPress Releases
Pharvaris Announces FDA Lifting of the Clinical Hold of Deucrictibant for the Prophylactic Treatment of HAE Attacks
3M ago
PHVS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >